Lymphocytes are present within ethidium-bromide (EB)-demyelinated lesions in the central nervous system (CNS) and the possibility of its participation in accidental immune-mediated responses to the detached myelin sheaths can not be ruled out. This study aimed to investigate the consequences of immunosuppression with dexamethasone in CNS repair after local EB injection. Adult Wistar rats received 10 microlitres of 0.1% EB solution into the cisterna pontis. Some were treated intraperitoneally with dexamethasone (3 mg/kg/day, group I, n=15) during the experimental period; others were not immunosuppressed (group II, n=15). Animals from both groups were perfused with 4% glutharaldehyde at 7,11,15,21 and 31 days following EB injection. Brainstem slices were collected and processed for transmission electron microscopy studies. Rats from group I showed greater amounts of myelin-derived membranes than non-immunosuppressed rats (group II), suggesting a delay in the macrophagic activity of removing myelin debris. Rare lymphocytes were found. Oligodendrocyte remyelinating activity also showed a delayed pattern, with clear predominance of naked axons.

Download full-text PDF

Source
http://dx.doi.org/10.1590/s0004-282x2004000100023DOI Listing

Publication Analysis

Top Keywords

injection brainstem
8
group n=15
8
rats group
8
[ultrastructural study
4
study remyelinating
4
remyelinating process
4
process local
4
local ethidium
4
ethidium bromide
4
bromide injection
4

Similar Publications

Hyperpolarized-C magnetic resonance imaging (HP-C MRI) was used to image changes in C-lactate signal during a visual stimulus condition in comparison to an eyes-closed control condition. Whole-brain C-pyruvate, C-lactate and C-bicarbonate production was imaged in healthy volunteers (N = 6, ages 24-33) for the two conditions using two separate hyperpolarized C-pyruvate injections. BOLD-fMRI scans were used to delineate regions of functional activation.

View Article and Find Full Text PDF

Background/objectives: Glioblastoma multiforme (GBM) is the most common high-grade primary brain cancer in adults. Despite efforts to advance treatment, GBM remains treatment resistant and inevitably progresses after first-line therapy. Induced neural stem cell (iNSC) therapy is a promising, personalized cell therapy approach that has been explored to circumvent challenges associated with the current GBM treatment.

View Article and Find Full Text PDF

Background: Meal variety promotes overconsumption by delaying sensory-specific-satiety (SSS), the transient reduction in reward value of a recently consumed food. Despite its role in meal cessation, the neuroendocrine mechanisms underlying SSS are largely unknown.

Methods: Here, we developed a preclinical model of SSS wherein rats consume more of a different food compared to the same food presented again, leading to greater caloric intake.

View Article and Find Full Text PDF

Background: Multiple sclerosis (MS) is an autoimmune disorder affecting the central nervous system, with varying clinical manifestations such as optic neuritis, sensory disturbances, and brainstem syndromes. Disease progression is monitored through methods like MRI scans, disability scales, and optical coherence tomography (OCT), which can detect retinal thinning, even in the absence of optic neuritis. MS progression involves neurodegeneration, particularly trans-synaptic degeneration, which extends beyond the initial injury site.

View Article and Find Full Text PDF

Bone marrow mesenchymal stem cells derived cytokines associated with AKT/IAPs signaling ameliorate Alzheimer's disease development.

Stem Cell Res Ther

January 2025

NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, International Center for Technology and Innovation of Animal Model, Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical College (PUMC), Beijing, 100021, China.

Background: Alzheimer's disease (AD) is a progressive neurodegenerative condition affecting around 50 million people worldwide. Bone marrow-derived mesenchymal stem cells (BMMSCs) have emerged as a promising source for cellular therapy due to their ability to differentiate into multiple cell types and their paracrine effects. However, the direct injection of BMMSCs can lead to potential unpredictable impairments, prompting a renewed interest in their paracrine effects for AD treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!